3 December 2021

Updated 3rd December 2021

The WMS has provided advice for people with neuromuscular disorders, and their healthcare providers since the start of the COVID-19 pandemic. This is a document aiming to answer questions regarding vaccines and vaccination against Coronavirus SARS-CoV2 asked by people with neuromuscular disorders. This is a rapidly developing field, and the WMS will keep this advice in regular review.

 

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern